Press release
Primary Immunodeficiency Diseases Market Insights, Forecast to 2031 | Abbott Laboratories, AstraZeneca, Pfizer, Baxter International, Inc.
Primary Immunodeficiency Diseases Market || 2024-2031
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/primary-immunodeficiency-diseases-market
What is the projected growth rate (CAGR) of the Global Primary Immunodeficiency Diseases market from 2024 to 2031, and what is the market value expected to change by 2031?
The Primary Immunodeficiency Diseases Market reached US$ 7.3 billion in 2023 and is expected to reach US$ 13.0 billion by 2031, growing at a CAGR of 7.6% during the forecast period 2024-2031.
The Primary Immunodeficiency Diseases (PIDD) Market focuses on treatments for a group of rare genetic disorders where the immune system is unable to function properly, leading to increased susceptibility to infections. The market is driven by advances in immunotherapy, gene therapy, and antibody replacement therapies, with increasing awareness and early diagnosis fueling growth. Rising demand for personalized treatments is also shaping the market landscape.
Key Developments:
On September 12, 2023, Abbott completed the acquisition of Bigfoot Biomedical, a move that strengthens Abbott's position in the diabetes care and insulin management systems market, allowing the company to expand its capabilities in addressing the needs of individuals with diabetes.
On August 9, 2022, CSL Behring acquired Vifor Pharmaceuticals, a strategic acquisition that has significantly enhanced CSL Behring's presence in the therapeutics sector, particularly in the treatment of iron deficiency and related conditions.
List of the Key Players in the Primary Immunodeficiency Diseases Market:
Abbott Laboratories, AstraZeneca, Pfizer, Baxter International, Inc., Bayer, Bristol Myers Squibb, Eli Lilly, Biotest AG, Grifols, CSL Behring among others.
Research Process:
Both primary and secondary data sources have been used in the global Primary Immunodeficiency Diseases Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Primary Immunodeficiency Diseases Market:
By Disease Type: Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders.
By Treatment: Immunoglobulin (Ig) Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy, Others.
By End-User: Hospitals, Specialty Clinics, Academic and research centers, Others.
Regional Breakout:
The global Primary Immunodeficiency Diseases Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
✫ North America (U.S., Canada, Mexico)
✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=primary-immunodeficiency-diseases-market
This Report Unveils:
✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.
✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.
✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.
✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.
✔ Identify high-potential niche segments and regions poised for significant expansion.
✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.
✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Primary Immunodeficiency Diseases manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Primary Immunodeficiency Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Primary Immunodeficiency Diseases market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Primary Immunodeficiency Diseases market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/primary-immunodeficiency-diseases-market
Frequently Asked Questions
☞ What is the expected growth rate of the global Primary Immunodeficiency Diseases market for the forecast period?
☞ What are the key driving factors that are responsible to shape the fate of the Primary Immunodeficiency Diseases market during the forecast period?
☞ What will be the overall size of the market during the analysis period?
☞ What are the prominent market trends which influence the development of the Primary Immunodeficiency Diseases market across various regions?
☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Primary Immunodeficiency Diseases market?
☞ What are the major opportunities that the companies can get to attain success in the world?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Immunodeficiency Diseases Market Insights, Forecast to 2031 | Abbott Laboratories, AstraZeneca, Pfizer, Baxter International, Inc. here
News-ID: 3732081 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Immunodeficiency
Severe Combined Immunodeficiency (SCID) Market: A Comprehensive Overview
Severe Combined Immunodeficiency (SCID) is a rare but life-threatening genetic disorder that affects the immune system, leaving individuals vulnerable to infections. It is often referred to as "bubble boy disease," due to its dramatic impact on the immune system, which fails to protect the body from pathogens. SCID can be caused by various mutations in different genes, and it leads to a complete or near-complete absence of functional T-cells and…
Rising Immunodeficiency Cases contribute to Global Immunoglobulin Market Growth
Inkwood Research estimates the Global Immunoglobulin Market to propel with a 14.67% CAGR during the forecasted period between 2022 and 2030, generating $18312.57 million in revenue by 2030.
Immunoglobulin Market: https://inkwoodresearch.com/reports/immunoglobulin-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
Browse 76 market Data Tables and 57 Figures spread over 226 Pages, along with an in-depth analysis of the Global Immunoglobulin Market by Product, Mode of Delivery, Application, Distribution Channel, End-User, & Geography.
This insightful market research report by Inkwood Research focuses…
Rising Immunodeficiency Cases contribute to Global Immunoglobulin Market Growth
Inkwood Research estimates the Global Immunoglobulin Market to propel with a 14.67% CAGR during the forecasted period between 2022 and 2030, generating $18312.57 million in revenue by 2030.
Browse 76 market Data Tables and 57 Figures spread over 226 Pages, along with an in-depth analysis of the Global Immunoglobulin Market by Product, Mode of Delivery, Application, Distribution Channel, End-User, & Geography.
This insightful market research report by Inkwood Research focuses on market…
Primary Immunodeficiency Sales Projected to Reach US$ 9.9 Billion by 2028, as In …
The global Primary Immunodeficiency market is estimated to attain a valuation of US$ 9.9 Bn by the end of 2028, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2020 - 2028.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading…
Turkey Primary Immunodeficiency Market Development, Trends, Segmentation Analysi …
Primary Immunodeficiency Market: Introduction
Transparency Market Research has published a new report titled, 'Global Primary Immunodeficiency Market '. According to the report, the global primary immunodeficiency market was valued at US$ 5.7 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2028. The primary immunodeficiency disorders (PIDs) are clinically heterogeneous disorders, the majority of which arise from genetic defects in immunologically relevant genes. Primary…
Primary Immunodeficiency Diseases Treatment Market 2021 | Detailed Report
The Primary Immunodeficiency Diseases Treatment research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Primary Immunodeficiency Diseases Treatment research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Get Free…
